|
1
|
Li D, Xie K, Wolff R and Abbruzzese JL:
Pancreatic cancer. Lancet. 363:1049–1057. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yokoyama Y, Nimura Y and Nagino M:
Advances in the treatment of pancreatic cancer: Limitations of
surgery and evaluation of new therapeutic strategies. Surg Today.
39:466–475. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sun HD, Huang SX and Han QB: Diterpenoids
from Isodon species and their biological activities. Nat Prod Rep.
23:673–698. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu QX, Yuan SX, Ren CM, Yu Y, Sun WJ, He
BC and Wu K: Oridonin upregulates PTEN through activating p38 MAPK
and inhibits proliferation in human colon cancer cells. Oncol Rep.
35:3341–3348. 2016.PubMed/NCBI
|
|
5
|
Gao S, Tan H, Zhu N, Gao H, Lv C, Gang J
and Ji Y: Oridonin induces apoptosis through the mitochondrial
pathway in human gastric cancer SGC-7901 cells. Int J Oncol.
48:2453–2460. 2016.PubMed/NCBI
|
|
6
|
Zhang XH, Liu YX, Jia M, Han JS, Zhao M,
Ji SP and Li AM: Oridonin inhibits tumor growth in glioma by
inducing cell cycle arrest and apoptosis. Cell Mol Biol. 60:29–36.
2014.
|
|
7
|
Dong Y, Zhang T, Li J, Deng H, Song Y,
Zhai D, Peng Y, Lu X, Liu M, Zhao Y, et al: Oridonin inhibits tumor
growth and metastasis through anti-angiogenesis by blocking the
Notch signaling. PLoS One. 9:e1138302014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kozomara A and Griffiths-Jones S: miRBase:
Integrating microRNA annotation and deep-sequencing data. Nucleic
Acids Res. 39(Database): D152–D157. 2011. View Article : Google Scholar :
|
|
11
|
Zidar N, Boštjančič E, Jerala M, Kojc N,
Drobne D, Štabuc B and Glavač D: Down-regulation of microRNAs of
the miR-200 family and up-regulation of Snail and Slug in
inflammatory bowel diseases - hallmark of epithelial-mesenchymal
transition. J Cell Mol Med. 20:1813–1820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chung VY, Tan TZ, Tan M, Wong MK, Kuay KT,
Yang Z, Ye J, Muller J, Koh CM, Guccione E, et al:
GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian
cancer through transcriptional regulation and histone modification.
Sci Rep. 6:199432016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cervantes-Arias A, Pang LY and Argyle DJ:
Epithelial-mesenchymal transition as a fundamental mechanism
underlying the cancer phenotype. Vet Comp Oncol. 11:169–184. 2013.
View Article : Google Scholar
|
|
15
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zeng F, Xue M, Xiao T, Li Y, Xiao S, Jiang
B and Ren C: MiR-200b promotes the cell proliferation and
metastasis of cervical cancer by inhibiting FOXG1. Biomed
Pharmacother. 79:294–301. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu H, Wang G, Wang Z, An S, Ye P and Luo
S: A negative feedback loop between miR-200b and the NF-kappaB
pathway via IKBKB/IKK-beta in breast cancer cells. FEBS J.
283:2259–2271. 2015. View Article : Google Scholar
|
|
18
|
Zhang HF, Alshareef A, Wu C, Li S, Jiao
JW, Cao HH, Lai R, Xu LY and Li EM: Loss of miR-200b promotes
invasion via activating the Kindlin-2/integrin β1/AKT pathway in
esophageal squamous cell carcinoma: An E-cadherin-independent
mechanism. Oncotarget. 6:28949–28960. 2015.PubMed/NCBI
|
|
19
|
Gui Z, Li S, Liu X, Xu B and Xu J:
Oridonin alters the expression profiles of microRNAs in BxPC-3
human pancreatic cancer cells. BMC Complement Altern Med.
15:1172015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Y, Li M, Wang H, Fisher WE, Lin PH,
Yao Q and Chen C: Profiling of 95 microRNAs in pancreatic cancer
cell lines and surgical specimens by real-time PCR analysis. World
J Surg. 33:698–709. 2009. View Article : Google Scholar
|
|
22
|
Sun M, Estrov Z, Ji Y, Coombes KR, Harris
DH and Kurzrock R: Curcumin (diferuloylmethane) alters the
expression profiles of microRNAs in human pancreatic cancer cells.
Mol Cancer Ther. 7:464–473. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sakurai MA, Ozaki Y, Okuzaki D, Naito Y,
Sasakura T, Okamoto A, Tabara H, Inoue T, Hagiyama M, Ito A, et al:
Gefitinib and luteolin cause growth arrest of human prostate cancer
PC-3 cells via inhibition of cyclin G-associated kinase and
induction of miR-630. PLoS One. 9:e1001242014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu N, Wu GC, Hu R, Li M and Feng H:
Ginsenoside Rh2 inhibits glioma cell proliferation by targeting
microRNA-128. Acta Pharmacol Sin. 32:345–353. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Y, Liu G, Wu S, Jiang F, Xie J and
Wang Y: Zinc finger E-box-binding homeobox 1: Its clinical
significance and functional role in human thyroid cancer. Onco
Targets Ther. 9:1303–1310. 2016.PubMed/NCBI
|
|
26
|
Li YJ, Ping C, Tang J and Zhang W:
MicroRNA-455 suppresses non-small cell lung cancer through
targeting ZEB1. Cell Biol Int. 40:621–628. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hou L, Li Q, Yu Y, Li M and Zhang D: SET8
induces epithelial-mesenchymal transition and enhances prostate
cancer cell metastasis by cooperating with ZEB1. Mol Med Rep.
13:1681–1688. 2016.PubMed/NCBI
|
|
28
|
Zhang G, An H and Fang X: MicroRNA-144
regulates proliferation, invasion, and apoptosis of cells in
malignant solitary pulmonary nodule via zinc finger E-box-binding
homeobox 1. Int J Clin Exp Pathol. 8:5960–5967. 2015.PubMed/NCBI
|
|
29
|
Inuzuka T, Tsuda M, Kawaguchi H and Ohba
Y: Transcription factor 8 activates R-Ras to regulate angiogenesis.
Biochem Biophys Res Commun. 379:510–513. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kundu ST, Byers LA, Peng DH, Roybal JD,
Diao L, Wang J, Tong P, Creighton CJ and Gibbons DL: The miR-200
family and the miR-183~96~182 cluster target Foxf2 to inhibit
invasion and metastasis in lung cancers. Oncogene. 35:173–186.
2016. View Article : Google Scholar
|
|
31
|
Xue L, Su D, Li D, Gao W, Yuan R and Pang
W: MiR-200 regulates epithelial-mesenchymal transition in
anaplastic thyroid cancer via EGF/EGFR signaling. Cell Biochem
Biophys. 72:185–190. 2015. View Article : Google Scholar
|
|
32
|
Shen A, Lin W, Chen Y, Liu L, Chen H,
Zhuang Q, Lin J, Sferra TJ and Peng J: Pien Tze Huang inhibits
metastasis of human colorectal carcinoma cells via modulation of
TGF-β1/ZEB/miR-200 signaling network. Int J Oncol. 46:685–690.
2015.
|
|
33
|
Rhodes LV, Martin EC, Segar HC, Miller DF,
Buechlein A, Rusch DB, Nephew KP, Burow ME and Collins-Burow BM:
Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the
inhibition of epithelial-to-mesenchymal transition in
triple-negative breast cancer. Oncotarget. 6:16638–16652. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu L, Qiu M, Tan G, Liang Z, Qin Y, Chen
L, Chen H and Liu J: miR-200c inhibits invasion, migration and
proliferation of bladder cancer cells through down-regulation of
BMI-1 and E2F3. J Transl Med. 12:3052014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Williams LV, Veliceasa D, Vinokour E and
Volpert OV: miR-200b inhibits prostate cancer EMT, growth and
metastasis. PLoS One. 8:e839912013. View Article : Google Scholar
|
|
36
|
Lu Y, Lu J, Li X, Zhu H, Fan X, Zhu S,
Wang Y, Guo Q, Wang L, Huang Y, et al: MiR-200a inhibits
epithelial-mesenchymal transition of pancreatic cancer stem cell.
BMC Cancer. 14:852014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xu L, Li Q, Xu D, Wang Q, An Y, Du Q,
Zhang J, Zhu Y and Miao Y: hsa-miR-141 downregulates TM4SF1 to
inhibit pancreatic cancer cell invasion and migration. Int J Oncol.
44:459–466. 2014.
|
|
38
|
Paik WH, Song BJ, Kim HW, Kim HR and Hwang
JH: MicroRNA-200c as a prognostic biomarker for pancreatic cancer.
Korean J Gastroenterol. 66:215–220. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Song B, Zheng K, Ma H, Liu A, Jing W, Shao
C, Li G and Jin G: miR-429 determines poor outcome and inhibits
pancreatic ductal adenocarcinoma growth by targeting TBK1. Cell
Physiol Biochem. 35:1846–1856. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen RY, Xu B, Chen SF, Chen SS, Zhang T,
Ren J and Xu J: Effect of oridonin-mediated hallmark changes on
inflammatory pathways in human pancreatic cancer (BxPC-3) cells.
World J Gastroenterol. 20:14895–14903. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kamitani S, Yamauchi Y, Kawasaki S, Takami
K, Takizawa H, Nagase T and Kohyama T: Simultaneous stimulation
with TGF-β1 and TNF-α induces epithelial mesenchymal transition in
bronchial epithelial cells. Int Arch Allergy Immunol. 155:119–128.
2011. View Article : Google Scholar
|
|
42
|
Doerner AM and Zuraw BL: TGF-beta1 induced
epithelial to mesenchymal transition (EMT) in human bronchial
epithelial cells is enhanced by IL-1beta but not abrogated by
corticosteroids. Respir Res. 10:1002009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wilson CB, Leopard J, Cheresh DA and
Nakamura RM: Extracellular matrix and integrin composition of the
normal bladder wall. World J Urol. 14(Suppl 1): S30–S37. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Topalovski M and Brekken RA: Matrix
control of pancreatic cancer: New insights into fibronectin
signaling. Cancer Lett. 381:252–258. 2015. View Article : Google Scholar
|
|
45
|
Di D, Chen L, Wang L, Sun P, Liu Y, Xu Z
and Ju J: Downregulation of human intercellular adhesion molecule-1
attenuates the metastatic ability in human breast cancer cell
lines. Oncol Rep. 35:1541–1548. 2016.PubMed/NCBI
|
|
46
|
Liu JF, Tsao YT and Hou CH: Amphiregulin
enhances inter-cellular adhesion molecule-1 expression and promotes
tumor metastasis in human osteosarcoma. Oncotarget. 6:40880–40895.
2015.PubMed/NCBI
|
|
47
|
Tai HC, Chang AC, Yu HJ, Huang CY, Tsai
YC, Lai YW, Sun HL, Tang CH and Wang SW: Osteoblast-derived
WNT-induced secreted protein 1 increases VCAM-1 expression and
enhances prostate cancer metastasis by down-regulating miR-126.
Oncotarget. 5:7589–7598. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Theurkauf WE, Smiley S, Wong ML and
Alberts BM: Reorganization of the cytoskeleton during Drosophila
oogenesis: Implications for axis specification and intercellular
transport. Development. 115:923–936. 1992.PubMed/NCBI
|
|
49
|
Wu L, Wang X, Liu Q, Wingnang Leung A,
Wang P and Xu C: Sinoporphyrin sodium mediated photodynamic therapy
inhibits the migration associated with collapse of F-actin
filaments cytoskeleton in MDA-MB-231 cells. Photodiagnosis Photodyn
Ther. 13:58–65. 2015. View Article : Google Scholar
|
|
50
|
da Silva PL, do Amaral VC, Gabrielli V,
Montt Guevara MM, Mannella P, Baracat EC, Soares-Jr JM and
Simoncini T: Prolactin promotes breast bancer bell migration
through actin cytoskeleton remodeling. Front Endocrinol (Lausanne).
6:1862015.
|
|
51
|
Li L and Yang XJ: Tubulin acetylation:
Responsible enzymes, biological functions and human diseases. Cell
Mol Life Sci. 72:4237–4255. 2015. View Article : Google Scholar : PubMed/NCBI
|
